
FDA turmoil after top drug regulator resigns
The FDA is roiled by the resignation of George Tidmarsh, former head of the Center for Drug Evaluation and Research, after a lawsuit by Aurinia Pharmaceuticals alleged he defamed its lupus nephritis drug on LinkedIn, spurring a 20 percent stock drop, and sought revenge against board chair Kevin Tang—claims he...








